JP2012521355A5 - - Google Patents

Download PDF

Info

Publication number
JP2012521355A5
JP2012521355A5 JP2012500991A JP2012500991A JP2012521355A5 JP 2012521355 A5 JP2012521355 A5 JP 2012521355A5 JP 2012500991 A JP2012500991 A JP 2012500991A JP 2012500991 A JP2012500991 A JP 2012500991A JP 2012521355 A5 JP2012521355 A5 JP 2012521355A5
Authority
JP
Japan
Prior art keywords
medicament
use according
administered
burns
topically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012500991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012521355A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/027953 external-priority patent/WO2010120431A2/en
Publication of JP2012521355A publication Critical patent/JP2012521355A/ja
Publication of JP2012521355A5 publication Critical patent/JP2012521355A5/ja
Pending legal-status Critical Current

Links

JP2012500991A 2009-03-20 2010-03-19 熱傷及び二次性合併症の予防及び治療方法 Pending JP2012521355A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US16206009P 2009-03-20 2009-03-20
US61/162,060 2009-03-20
US24965809P 2009-10-08 2009-10-08
US61/249,658 2009-10-08
US25853309P 2009-11-05 2009-11-05
US61/258,533 2009-11-05
US25934909P 2009-11-09 2009-11-09
US61/259,349 2009-11-09
PCT/US2010/027953 WO2010120431A2 (en) 2009-03-20 2010-03-19 Methods for the prevention and treatment of burn injuries and secondary complications

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014211820A Division JP6005707B2 (ja) 2009-03-20 2014-10-16 熱傷及び二次性合併症の予防及び治療方法

Publications (2)

Publication Number Publication Date
JP2012521355A JP2012521355A (ja) 2012-09-13
JP2012521355A5 true JP2012521355A5 (https=) 2013-05-16

Family

ID=42983062

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2012500991A Pending JP2012521355A (ja) 2009-03-20 2010-03-19 熱傷及び二次性合併症の予防及び治療方法
JP2014211820A Active JP6005707B2 (ja) 2009-03-20 2014-10-16 熱傷及び二次性合併症の予防及び治療方法
JP2016174286A Pending JP2016210801A (ja) 2009-03-20 2016-09-07 熱傷及び二次性合併症の予防及び治療方法
JP2018153359A Pending JP2018172442A (ja) 2009-03-20 2018-08-17 熱傷及び二次性合併症の予防及び治療方法
JP2020150963A Pending JP2020196762A (ja) 2009-03-20 2020-09-09 熱傷及び二次性合併症の予防及び治療方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2014211820A Active JP6005707B2 (ja) 2009-03-20 2014-10-16 熱傷及び二次性合併症の予防及び治療方法
JP2016174286A Pending JP2016210801A (ja) 2009-03-20 2016-09-07 熱傷及び二次性合併症の予防及び治療方法
JP2018153359A Pending JP2018172442A (ja) 2009-03-20 2018-08-17 熱傷及び二次性合併症の予防及び治療方法
JP2020150963A Pending JP2020196762A (ja) 2009-03-20 2020-09-09 熱傷及び二次性合併症の予防及び治療方法

Country Status (5)

Country Link
US (5) US20100331265A1 (https=)
EP (4) EP3563862B1 (https=)
JP (5) JP2012521355A (https=)
CN (2) CN102573881A (https=)
WO (1) WO2010120431A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3563862B1 (en) * 2009-03-20 2021-05-05 The General Hospital Corporation d/b/a Massachusetts General Hospital D-arg-2'6'-dimethyltyrosine-lys-phe-nh2 for use in the prevention of secondary complications of burn injuries
PL2470191T3 (pl) 2009-08-24 2014-09-30 Stealth Peptides Int Inc Sposoby i kompozycje do profilaktyki lub leczenia stanów okulistycznych
EP2485749A4 (en) 2009-10-05 2013-07-24 Univ Cornell METHOD FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
EP3332795A1 (en) * 2010-02-26 2018-06-13 Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy
JP2013532124A (ja) * 2010-05-03 2013-08-15 ステルス ペプチドズ インターナショナル インコーポレイテッド 芳香族系陽イオンペプチド及びその使用
AU2012315586B2 (en) 2011-09-29 2017-07-20 Mayo Foundation For Medical Education And Research Aromatic-cationic peptides and methods for using same
JP6317324B2 (ja) * 2012-03-30 2018-04-25 ステルス ペプチドズ インターナショナル インコーポレイテッド 神経障害を予防および処置するための方法および組成物
EP3626252A1 (en) 2013-03-01 2020-03-25 Stealth Biotherapeutics Corp Methods and compositions for the prevention or treatment of barth syndrome
CN110339339A (zh) 2013-03-01 2019-10-18 康德生物医疗技术公司 治疗线粒体疾病的方法
US10047395B2 (en) 2013-06-26 2018-08-14 Stealth Biotherapeutics Corp Methods and compositions for detecting and diagnosing diseases and conditions
CN109069572A (zh) * 2015-12-31 2018-12-21 康德生物医疗技术公司 包含肽的治疗性组合物和其用途
CN115160402A (zh) * 2016-03-11 2022-10-11 隐形生物治疗公司 结晶盐形式
CA3020393A1 (en) * 2016-04-11 2017-10-19 Carnot, Llc Chiral peptides
JP7427448B2 (ja) 2018-08-23 2024-02-05 積水化学工業株式会社 合わせガラス用中間膜、合わせガラス、及びガラス構成体

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP0350221B1 (en) * 1988-06-30 1996-04-17 Astra Aktiebolag Dermorphin analogs, their methods of preparation, pharmaceutical compositions, and methods of therapeutic treatment using the same
US5602100A (en) * 1988-06-30 1997-02-11 Astra Ab Dermorphin analogs having pharmacological activity
US5670617A (en) * 1989-12-21 1997-09-23 Biogen Inc Nucleic acid conjugates of tat-derived transport polypeptides
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US5674534A (en) * 1992-06-11 1997-10-07 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
US5716644A (en) * 1992-06-11 1998-02-10 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
ATE255450T1 (de) * 1995-06-09 2003-12-15 Hisamitsu Pharmaceutical Co Matrix für iontophorese
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5885958A (en) * 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
CA2314267A1 (en) * 1997-12-10 1999-06-17 Washington University Anti-pathogen system and methods of use thereof
JP2002512954A (ja) * 1998-04-24 2002-05-08 マイトコー ミトコンドリア関連疾患を処置するための化合物および方法
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
SE9900961D0 (sv) * 1999-03-16 1999-03-16 Astra Ab Novel compounds
WO2001012130A1 (en) * 1999-08-16 2001-02-22 Dung Phan Compositions and methods of treatment for skin conditions using extracts of turmeric
AU7855900A (en) * 1999-10-04 2001-05-10 University Of Medicine And Dentistry Of New Jersey Methods for identifying rna binding compounds
US6759520B1 (en) * 1999-10-28 2004-07-06 The New England Medical Center Hospitals, Inc. Chimeric analgesic peptides
US20050192215A1 (en) * 2000-01-21 2005-09-01 Malabika Ghosh Methods and materials relating to novel polypeptides and polynucleotides
EP1303186B1 (en) * 2000-07-18 2011-01-26 Cornell Research Foundation, Inc. Medicinal uses of mu-opioid receptor agonists
US6900178B2 (en) * 2000-09-12 2005-05-31 University Of Kentucky Research Foundation Protection against ischemia and reperfusion injury
US20070015146A1 (en) 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
JP2006505290A (ja) * 2002-11-10 2006-02-16 インスティテュート オブ セル バイオフィジクス ロシアン アカデミー オブ サイエンシーズ 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法
SI2656854T1 (sl) * 2003-02-04 2015-09-30 Cornell Research Foundation, Inc. Uporabe aromatsko-kationskega peptida
JP4879020B2 (ja) * 2003-05-01 2012-02-15 コーネル リサーチ ファウンデイション インコーポレイテッド 細胞に分子を送達する方法及び担体複合体
EP1667684A1 (en) * 2003-09-17 2006-06-14 ICOS Corporation Use of chk1 inhibitors to control cell proliferation
US7232824B2 (en) * 2003-09-30 2007-06-19 Scios, Inc. Quinazoline derivatives as medicaments
CA2851972C (en) * 2004-01-23 2015-06-23 Cornell Research Foundation, Inc. Methods for reducing oxidative damage
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
US7804249B2 (en) * 2004-09-15 2010-09-28 Koninklijke Philips Electronics N.V. Light-transmitting substrate provided with a light-absorbing coating, light absorbing coating as well as method of preparing a light-absorbing coating
CA2947335A1 (en) * 2005-09-16 2007-03-29 Cornell Research Foundation, Inc. Methods for reducing cd36 expression
US20070259377A1 (en) * 2005-10-11 2007-11-08 Mickey Urdea Diabetes-associated markers and methods of use thereof
US20080027082A1 (en) * 2006-06-19 2008-01-31 Berthold Hocher Use of adenosine a1 antagonists in radiocontrast media induced nephropathy
WO2008063558A2 (en) * 2006-11-17 2008-05-29 Schering Corporation Combination of an inhibitor of dna polymerase-alpha and an inhibitor of a checkpoint kinase for proliferative disorders
EP3103467A1 (en) * 2008-02-07 2016-12-14 Cornell University Methods for preventing or treating insulin resistance
DK2262520T3 (en) * 2008-02-26 2017-08-07 Univ Cornell COMPOSITIONS FOR PREVENTION AND TREATMENT OF Kidney Injury
JP6005359B2 (ja) * 2008-08-28 2016-10-12 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 対象のサイズの変更を決定する装置
EP3563862B1 (en) * 2009-03-20 2021-05-05 The General Hospital Corporation d/b/a Massachusetts General Hospital D-arg-2'6'-dimethyltyrosine-lys-phe-nh2 for use in the prevention of secondary complications of burn injuries

Similar Documents

Publication Publication Date Title
JP2012521355A5 (https=)
JP2023002662A5 (https=)
JP2020033360A5 (https=)
JP2008535867A5 (https=)
JP2009102342A5 (https=)
RU2015107877A (ru) Способы лечения болезни альцгеймера и фармацевтические композиции
JP2013522303A5 (https=)
JP2021530554A5 (https=)
RU2013155509A (ru) Применение ингибирования катепсина к для лечения и/или профилактики легочной гипертензии и/или сердечной недостаточности
JP2015508765A5 (https=)
JP2018531273A5 (https=)
JP2021512921A5 (https=)
JP2012525358A5 (https=)
JP2020500868A5 (https=)
ES2773711T3 (es) Un metabolito de iloperidona para uso en el tratamiento de trastornos psiquiátricos
WO2023155837A1 (zh) 具有镇痛和/或止痒功能的药物组合物及其用途
CN113876775B (zh) 一种青藤碱或其药物可接受的盐作为治疗动脉性肺动脉高压药物的用途
JP2019509309A5 (https=)
JP2021506907A5 (https=)
CN109310669B (zh) 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途
JP2013518061A5 (https=)
CN109758452A (zh) 胺类化合物治疗疼痛的医药用途
JP2023523247A (ja) ウイルス感染症の治療のためのレニン－アンジオテンシン系（ｒａｓ）モジュレーター、それを含む医薬組成物、およびそれを用いた治療方法
PT1309322E (pt) Utilização de derivados do ácido 3-benzoílfenilacético para o tratamento de afecções da retina
JP5386478B2 (ja) パーキンソン病に伴う運動不全の治療のための４−シクロプロピルメトキシ−ｎ−（３，５−ジクロロ−１−オキシドピリジン−４−イル）−５−（メトキシ）ピリジン−２−カルボキサミドの使用